(Q44036228)

29 November 2017

title

Antiretroviral therapy and immunologic reconstitution in AIDS. (English)

1 reference

29 November 2017

0 references

anti-retroviral agent

0 references

1

A S Fauci

1 reference

29 November 2017

2

H C Lane

1 reference

29 November 2017

publication date

1 March 1987

1 reference

Annales de l'Institut Pasteur. Immunologie

29 November 2017

published in

1 reference

29 November 2017

volume

138

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

261-268

1 reference

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

What to call the AIDS virus?

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Acquired Immunodeficiency Syndrome: Epidemiologic, Clinical, Immunologic, and Therapeutic Considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

NIH conference. The acquired immunodeficiency syndrome: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Infection of monocyte/macrophages by human T lymphotropic virus type III.

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Partial immune reconstitution in a patient with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

HTLV-III infection in brains of children and adults with AIDS encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Phosphonoformate Inhibits Reverse Transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0769-2625%2887%2980077-6

7 January 2021

10.1016/S0769-2625(87)80077-6

Identifiers

DOI

1 reference

29 November 2017

1 reference